Koei Chemical Company, Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Koei Chemical Company, Limited with three other
companies in this sector in Japan:
Biofermin Pharmaceutical Company Limited
sales of 10.88 billion Japanese Yen [US$98.22 million]
of which 62%
was New BioferminS),
I'rom Group Co Ltd
(8.62 billion Japanese Yen [US$77.85 million]
of which 73%
was Smo Business), and
Wakamoto Pharmaceutical Co., Ltd.
(10.90 billion Japanese Yen [US$98.43 million]
of which 51%
was Medical Pharmaceutical Products).
Koei Chemical Company, Limited reported sales of ¥18.14 billion (US$163.84 million)
March of 2018.
increase of 5.0%
versus 2017, when the company's sales were ¥17.28 billion.
Despite this increase, sales are still
below the level achieved in 2016, when Koei Chemical Company, Limited
reported sales of ¥18.28 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Koei Chemical Company, Limited had sales
of ¥18.22 billion.